Astrana Health (ASTH) vs ICF International (ICFI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Astrana Health (ASTH) has outperformed ICF International (ICFI) over the past year, gaining 28.4% versus a loss of 0.6%. Over five years, ICFI leads with a -22.7% price change compared with -69.4% for ASTH. Astrana Health is the larger company by market cap ($1.44 billion vs $1.39 billion), about 1.0 times the size.
On valuation, Astrana Health trades at a lower forward P/E (8.3x vs 10.1x for ICF International). ICF International pays a dividend yielding 0.72%, while Astrana Health does not currently pay one. ICF International converts more of its revenue into profit, with a net margin of 4.9% versus 0.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | ICFI |
|---|---|---|
| Share price | $28.90 | $77.56 |
| Market cap | $1.44B | $1.39B |
| 1-day change | +0.77% | +1.45% |
| YTD return | +16.49% | -9.07% |
| 1-year return | +28.44% | -0.59% |
| 5-year return | -69.44% | -22.66% |
| P/E ratio (TTM) | 26.76 | 14.63 |
| Forward P/E | 8.30 | 10.12 |
| EPS (TTM) | $1.08 | $5.30 |
| Dividend yield | 0.00% | 0.72% |
| Annual dividend | $0.00 | $0.56 |
| Revenue (latest FY) | $3.18B | $1.87B |
| Revenue growth (YoY) | +56.39% | -7.27% |
| Net income (latest FY) | $22.49M | $91.59M |
| Gross margin | 10.73% | 37.16% |
| Operating margin | 2.47% | 7.77% |
| Net margin | 0.71% | 4.89% |
| 52-week high | $51.60 | $100.63 |
| 52-week low | $18.08 | $58.83 |
| Distance from 52-week high | -43.99% | -22.93% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +79.55% | +41.50% |
| Average volume | 377.18K | 183.90K |
| Shares outstanding | 49.67M | 17.94M |
| Employees | 3,000 | 6,972 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed ICFI by 29.0 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (26.8x vs 14.6x trailing P/E).
- Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs -7.27%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About ICF International
ICFI stock →ICF International, Inc. provides management, technology, and policy consulting and implementation services to government and commercial clients in the United States and internationally.
Consumer Discretionary · Professional Services · 6,972 employees
ASTH vs ICFI FAQ
Which is bigger, Astrana Health or ICF International?
Astrana Health (ASTH) is larger, with a market capitalization of $1.44B compared with $1.39B for ICF International (ICFI).
Which stock has performed better over the past year, ASTH or ICFI?
ASTH returned +28.44% over the past 12 months, compared with -0.59% for ICFI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or ICFI?
ICFI has the lower trailing P/E at 14.6, versus 26.8 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Astrana Health or ICF International?
ICF International pays a dividend yielding 0.72%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and ICF International in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.